These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 2247023)

  • 21. Erythrocyte, platelet and polymorphonuclear leukocyte membrane dynamic properties in essential hypertension.
    Caimi G
    Clin Hemorheol Microcirc; 1997; 17(3):199-208. PubMed ID: 9356784
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Alterations of erythrocyte lipid pattern and of some membrane related functions as a consequence of plasma lipid disorder in diabetes mellitus.
    Cignarelli M; Blonda M; Cospite MR; Damato A; Nardelli G; Giorgino R
    Diabete Metab; 1983 Dec; 9(4):272-6. PubMed ID: 6667763
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of metformin treatment on erythrocyte insulin binding in normal weight subjects, in obese non diabetic subjects, in type 1 and type 2 diabetic patients.
    Rizkalla SW; Elgrably F; Tchobroutsky G; Slama G
    Diabete Metab; 1986 Aug; 12(4):219-24. PubMed ID: 3533670
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impairment of sodium pump and Na/H exchanger in erythrocytes from non-insulin dependent diabetes mellitus patients: effect of tea catechins.
    Rizvi SI; Zaid MA
    Clin Chim Acta; 2005 Apr; 354(1-2):59-67. PubMed ID: 15748600
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Alteration of fatty acid components of erythrocyte membrane and insulin resistance in diabetic patients].
    Yang G; Li L; Dang H
    Zhonghua Yi Xue Za Zhi; 1998 Apr; 78(4):269-71. PubMed ID: 10923482
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Compositional alterations of erythrocyte membrane lipid and red cell deformability in diabetes].
    Qiu H
    Zhonghua Yi Xue Za Zhi; 1991 Jan; 71(1):21-3. PubMed ID: 1850649
    [No Abstract]   [Full Text] [Related]  

  • 27. Diabetes mellitus alters the effect of peptide and protein ligands on membrane fluidity of blood platelets.
    Watala C; Gwoździński K; Pluskota E; Pietrucha T; Walkowiak B; Trojanowski Z; Cierniewski CS
    Thromb Haemost; 1996 Jan; 75(1):147-53. PubMed ID: 8713794
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of erythrocyte morphology as deformability index in patients suffering from vascular diseases, with or without diabetes mellitus: correlation with blood viscosity and intra-erythrocytic calcium.
    Turchetti V; Leoncini F; De Matteis C; Trabalzini L; Guerrini M; Forconi S
    Clin Hemorheol Microcirc; 1998 Jul; 18(2-3):141-9. PubMed ID: 9699035
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long-chain omega6 polyunsaturated fatty acids in erythrocyte phospholipids are associated with insulin resistance in non-obese type 2 diabetics.
    Rodríguez Y; Christophe AB
    Clin Chim Acta; 2005 Apr; 354(1-2):195-9. PubMed ID: 15748617
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Observations of erythrocyte insulin receptor and membrane microviscosity of erythrocyte in type II diabetics].
    Zhang WR; He DH; Zhu XX; Zhong XL; Pan XP; Tao HG; Zhou YP
    Sheng Li Xue Bao; 1988 Oct; 40(5):518-22. PubMed ID: 3251364
    [No Abstract]   [Full Text] [Related]  

  • 31. Altered platelet functions in non-insulin-dependent diabetes mellitus (NIDDM).
    Srivastava S; Joshi CS; Sethi PP; Agrawal AK; Srivastava SK; Seth PK
    Thromb Res; 1994 Dec; 76(5):451-61. PubMed ID: 7900093
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Abnormal antioxidant status in impaired glucose tolerance and non-insulin-dependent diabetes mellitus.
    Vijayalingam S; Parthiban A; Shanmugasundaram KR; Mohan V
    Diabet Med; 1996 Aug; 13(8):715-9. PubMed ID: 8862945
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nitrite plasma levels in type 1 and 2 diabetics with and without complications.
    Ferlito S; Gallina M
    Panminerva Med; 1998 Dec; 40(4):304-8. PubMed ID: 9973826
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The effect of atorvastatin on erythrocyte membranes and serum lipids in patients with type-2 hypercholesterolemia.
    Koter M; Broncel M; Chojnowska-Jezierska J; Klikczynska K; Franiak I
    Eur J Clin Pharmacol; 2002 Nov; 58(8):501-6. PubMed ID: 12451426
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Membrane fluidity, membrane lipid pattern, and cytosolic Ca2+ content in platelets from a group of type II diabetic patients with macrovascular complications.
    Caimi G; Lo Presti R; Montana M; Canino B; Ventimiglia G; Romano A; Catania A; Sarno A
    Diabetes Care; 1995 Jan; 18(1):60-3. PubMed ID: 7698049
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Erythrocyte membrane fluidity in type 1 diabetes mellitus.
    Hill MA; Court JM
    Pathology; 1983 Oct; 15(4):449-51. PubMed ID: 6674874
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Compensatory mechanisms in erythrocyte lipids in patients with atherosclerosis.
    Michalak J; Kadziolka A; Pruszkowska R; Ledwozyw A; Madejczyk A
    Lipids; 1988 May; 23(5):476-80. PubMed ID: 3412128
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Rheologic determinant changes of erythrocytes in Binswanger's disease.
    Chen CF; Jia HY; Ma HW; Wang DY; Guo SS; Qu S
    Zhonghua Yi Xue Za Zhi (Taipei); 1999 Feb; 62(2):76-85. PubMed ID: 10063717
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Membrane lipid alterations and Na+-pumping activity in erythrocytes from IDDM and NIDDM subjects.
    Baldini P; Incerpi S; Lambert-Gardini S; Spinedi A; Luly P
    Diabetes; 1989 Jul; 38(7):825-31. PubMed ID: 2544470
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lowered membrane fluidity of younger erythrocytes in diabetes.
    Kamada T; McMillan DE; Yamashita T; Otsuji S
    Diabetes Res Clin Pract; 1992 Apr; 16(1):1-6. PubMed ID: 1576926
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.